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Abstract: 
Background.  Airway epithelial cell (AEC) function differs between children 
with and without asthma.  Here we associated neonatal AEC function with 
asthma symptoms at four years of age.  
Methods.  Nasal AEC were collected from neonates within 48 hours of 
birth.  Cells were cultured and stimulated with tumour necrosis factor 
alpha/interleukin-1 beta (TNFα/IL-1β), lipopolysaccharide (LPS) or house 
dust mite (HDM).  Absolute concentrations of pro-inflammatory mediators 
in the culture supernatant were quantified and expressed as median 
[interquartile range] in pg/mg protein.  A parent-completed respiratory 
questionnaire was returned when the child was four years old.  
Results.  AEC were successfully cultured in 139 neonates, of whom 120 
were contacted at four years and 91 (76%) questionnaires were returned. 
Sixteen children had wheezed ever and 11 had recent wheeze.  At birth, 
when compared to those with no recent wheeze, supernatants from 
cultured neonatal AEC from the children with recent wheeze had reduced 
median IL-8 (CXCL8) release after treatment with culture medium alone 
(p=0.049), with TNFα/IL-1β (p<0.001) and LPS (p=0.004). Additionally, 
and when compared to those with no recent wheeze, four year olds with 
recent wheeze had reduced neonatal AEC release of IL-6 (p=0.013), 
GMCSF (p=0.012) and ICAM-1 (p=0.017) after treatment with TNFα/IL-1β 
and reduced release of ICAM-1 (p=0.038) and RANTES (p=0.042) after 
treatment with HDM.    
Conclusions.  Abnormalities in AEC function are present at birth before the 
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onset of childhood wheeze.  The relationship between reduced AEC function 
at birth and wheeze at four years was not exclusive, suggesting that post-
natal factors are required for the AEC abnormality to translate into 
symptoms.    
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ABSTRACT 
Background.  Airway epithelial cell (AEC) function differs between children with and without 
asthma.  Here we associated neonatal AEC function with asthma symptoms at four years of 
age. 
Methods.  Nasal AEC were collected from neonates within 48 hours of birth.  Cells were 
cultured and stimulated with tumour necrosis factor alpha/interleukin-1 beta (TNFα/IL-1β), 
lipopolysaccharide (LPS) or house dust mite (HDM).  Absolute concentrations of pro-
inflammatory mediators in the culture supernatant were quantified and expressed as 
median [interquartile range] in pg/mg protein.  A parent-completed respiratory 
questionnaire was returned when the child was four years old. 
Results.  AEC were successfully cultured in 139 neonates, of whom 120 were contacted at 
four years and 91 (76%) questionnaires were returned. Sixteen children had wheezed ever 
and 11 had recent wheeze.  At birth, when compared to those with no recent wheeze, 
supernatants from cultured neonatal AEC from the children with recent wheeze had 
reduced median IL-8 (CXCL8) release after treatment with culture medium alone (p=0.049), 
with TNFα/IL-1β (p<0.001) and LPS (p=0.004). Additionally, and when compared to those 
with no recent wheeze, four year olds with recent wheeze had reduced neonatal AEC 
release of IL-6 (p=0.013), GMCSF (p=0.012) and ICAM-1 (p=0.017) after treatment with 
TNFα/IL-1β and reduced release of ICAM-1 (p=0.038) and RANTES (p=0.042) after treatment 
with HDM.   
Conclusions.  Abnormalities in AEC function are present at birth before the onset of 
childhood wheeze.  The relationship between reduced AEC function at birth and wheeze at 
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four years was not exclusive, suggesting that post-natal factors are required for the AEC 
abnormality to translate into symptoms.   
INTRODUCTION 
Asthma affects 5 million people in the UK, including 1.1 million children
1
.  There is currently 
no cure for asthma and this is largely due to our lack of understanding of asthma aetiology.  
What is known is that genetic factors explain between 35% and 95% of asthma causation
2
 
and that environmental factors are also important
3
.  Asthma symptoms usually begin in 
childhood
4
 and can persist into adult life
5,6
, and better understanding of the early origins of 
asthma may lead to novel interventions which palliate and cure symptoms. 
Bias in the differentiation of the cellular immune system, where T-helper type 2 (Th2) 
lymphocytes predominated over Th1, was traditionally thought to be the critical process in 
the development of asthma
7
. More recently the primacy of the cellular immune system in 
the development of asthma has been questioned
8
 and  airway epithelial cells (AEC) have 
been implicated in asthma causation
9
.  The AEC provides a physical barrier against 
penetration of environmental exposures into the respiratory tissues, and this cell layer is 
now understood to be an important component of the innate immune system.  
Furthermore, AEC function is known to be different in children and adults with asthma 
compared to their non-asthmatic peers
10–13
.  Although it is known that AEC abnormalities 
are present in asthma, the fundamental question as to whether this is present at birth, i.e. 
preceding the development of asthma and wheezing illness, remains unanswered. 
We have collected nasal AEC within 48 hours of birth in a cohort 
14
 and have followed up 
participants after four years.  Nasal cells were sampled due to the difficult practical and 
ethical issues of sampling bronchial AEC in healthy neonates, and five studies described in a 
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recent review
10
 have demonstrated similarities between nasal and bronchial AEC in a 
number of different settings. The aim of this study was to determine whether altered 
neonatal AEC pro-inflammatory responses constitute risk factors for later asthma 
symptoms.  Wheeze in young children is often transient and does not progress to asthma, 
especially wheeze before the third birthday
15
. Here we test the hypothesis that AEC function 
was abnormal at birth in those who have asthma symptoms at four years of age.  Since 
asthma is associated with atopic conditions such as eczema, we also stratified AEC function 
by asthma symptoms and eczema at four years of age.  Our primary AEC outcome was 
interleukin (IL)-8  (CXCL8), and this was chosen because the secretion of this pro-
inflammatory cytokine is enhanced by treatment with factors such as interleukin (IL)-1β and 
tumour necrosis factor alpha (TNFα) or house dust mite (HDM) in both neonatal nasal AEC
16
 
and bronchial AEC in children
17
.   
 
METHODS  
Study subjects 
Recruitment took place at 10-12 weeks gestation, and details of parental asthma, smoking 
and socioeconomic status were collected.  Within 48 hours of birth, nasal AEC were 
obtained by brushing and cultured in a submerged model
16
.  In a subset of individuals there 
were sufficient cells available for cultured AEC to also be exposed to lipopolysaccharide 
(LPS).  Close to the child’s fourth birthday a postal questionnaire was completed.  A third 
party
18
 with permissions to access the child’s contact details through Scottish healthcare 
records forwarded to parents of the study participants a questionnaire containing all the 
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respiratory module questions of the International Study of Asthma and Allergy in Children 
(ISAAC) and also the question from the ISAAC eczema module for 6-7 year olds “has your 
child ever had eczema?” 
19
. “Recent wheeze” was defined as wheeze in the last 12 months 
and was the primary outcome.  “Never wheeze” was defined as negative responses to both 
“ever wheeze” and “wheeze in the last 12 months” questions.  The recruitment phase of the 
study was approved by North of Scotland Research Ethics Service (reference number 
10/S0802/55) and the follow up phase was approved by East Midlands- Nottingham 2 
Research Ethics Committee (reference number 16/EM/0056).  Written parental consent was 
obtained. 
Nasal brushing, AEC culture and stimulation 
The medial aspect of the inferior turbinate of each nostril was gently brushed using one 
sterile 2.7 mm interdental brush (Dento Care Professional, London UK) .  Cells were placed 
into growth medium (Serum-free Bronchial Epithelial Growth Media, Lonza Ltd, Slough, UK) 
and cultured in submerged monolayers until confluence was reached.  At 3-4 weeks after 
harvesting, tertiary passage AEC were treated with : (i) 10 ng/mL Interleukin 1β (IL-1β, R&D, 
Abingdon, UK) and 10 ng/mL Tumour Necrosis Factor-α (TNF-α, R&D, Abingdon, UK); (ii) 25 
µg/mL House Dust Mite (HDM, Greer Laboratories, Lenoir, NC, USA); (iii) 100 µg/mL 
Lipopolysaccharide (LPS, Sigma-Aldrich Ltd, Poole, UK); and (iv) medium alone.  Growth 
medium was removed and replaced with 0.5 ml of either fresh medium or the same volume 
of medium supplemented with experimental treatment as appropriate. After 24 hours of 
treatment, culture supernatants were removed and centrifuged at 500 rpm for five minutes 
to remove cell debris before storing at -20
o
C for subsequent analysis.  The concentrations of 
the following cytokines and chemokines in the AEC medium were determined with 
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cytometric bead array (Becton Dickinson, Oxford, UK): vascular endothelial growth factor 
(VEGF), regulated on activation normal T-cell expressed and secreted (RANTES/CCL5), 
monocyte chemoattractant protein (MCP)-1/CCL2, IL-3, IL-6, IL-10, IL-17A, interferon (IFN)-γ, 
granulocyte macrophage colony stimulating factor (GMCSF), eotaxin, macrophage inhibitory 
proteins (MIP) 1α/CCL3 and 1β/CCL4, intracellular adhesion molecule (ICAM)-1 and tumour 
necrosis factor (TNF) α. Interleukin-8/CXCL8 concentrations were determined by enzyme 
linked immunosorbent assay (Biolegend, San Diego, CA, USA).  Once culture and exposure 
were complete and the overlay medium recovered, cells were lysed and the cellular protein 
content was determined by the Bradford Assay.  Cytokine/chemokine concentrations 
(pg/mL) in the 0.5mL overlay medium were normalised to AEC protein content and 
expressed as the pg/mg protein.  The effect of exposure on absolute difference in AEC 
cytokine/chemokine release was calculated as the concentrations after treatment with IL-
1β/TNFα, LPS, HDM or growth medium alone 
Analysis.  The Mann Whitney test was used to describe the significance of differences in 
cytokines/chemokines between children with recent wheeze and without recent wheeze 
and also between those with recent wheeze and never wheeze.  Where differences were 
seen between children with and without recent wheeze, cytokine/chemokine 
concentrations were compared across groups stratified by recent wheeze and eczema and 
significance determined using the Kruskal-Wallis test.  Standard statistical software was 
used (IBM SPSS, version 23.0.0) and a p value of <0.05 was considered significant. 
RESULTS 
Study subjects 
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There were 269 mothers recruited, 192 neonates were sampled (many were taken home 
prior to sampling), and AEC cultured in 139 individuals of whom 120 were contacted and 
their questionnaires returned by 91.  Table one compares details of the 269 initially 
recruited and the 91 where a questionnaire was returned; the latter subgroup had a higher 
birth weight and lower prevalence of maternal eczema compared to the whole population. 
There were 11 children with recent wheeze, 16 had a history of wheeze ever and 32 had a 
history of eczema.  No child had diagnosed asthma.  Wheeze outcome was related to AEC IL-
8 release after exposure to growth media alone in 91 individuals, to IL-1β/TNFα in 88, to 
HDM in 72 and to LPS exposure in 38 (cells died during exposure or there were insufficient 
cells available for exposure in all cases).  E-Table 1 demonstrates that those where results 
after treatment with IL-1β/TNFα, HDM and LPS were available were similar to the original 
population except for higher birth weight. 
Neonatal AEC cytokine/chemokine release and recent wheeze  
For AEC exposed only to growth medium, IL-8/CXCL8 release was lower in those with recent 
wheeze (median [IQR] 3530 pg/mg [1850, 6310]) compared to those with no recent wheeze 
(median 6829 [3850, 13948]), p=0.049), table 2, figure 1.  Children with recent wheeze had 
reduced AEC release of IL-8/CXCL8 after stimulation with IL-1β and TNFα compared to those 
without recent wheeze (p<0.001, figure 1).  Additionally, AEC release of IL-6 (0.013), GMCSF 
(p=0.012) and ICAM-1 (p=0.017) was reduced after stimulation with IL-1β and TNFα in those 
with recent wheeze compared to no recent wheeze (table 2).  The release of IL-8/CXCL8 was 
also reduced in children with recent wheeze after treatment with LPS (p=0.004) compared 
to those with no recent wheeze (table 2).  The AEC ICAM-1 (p=0.038, table 2) and 
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RANTES/CCL5 (p=0.042, table 2 on line supplement) response to HDM were reduced among 
individuals with recent wheeze compared to those without recent wheeze.   
We have previously reported associations between maternal dietary exposures during 
pregnancy and neonatal AEC release of TNFα, IL-10 and MIP-1α/CCL3
14
, and there were 
reductions in TNFα levels after LPS exposure among 5 children with recent wheeze (median 
concentration 5 pg/mg [1, 9]) compared to 31 without (median 11 [5, 19]) p=0.038. There 
was no association between recent wheeze and neonatal AEC release of VEGF, MCP-1/CCL2, 
IL-17A, IFN-ɣ, eotaxin or MIP-1β/CCL4 under any treatment conditions (see E-Tables 2-5 in 
the online supplement).  The differences in cytokine/chemokine responses between 
children with recent wheeze and a history of wheeze but not recent wheeze were also seen 
for the comparison between children with recent wheeze and never wheeze (online 
supplement E-Table 6).  
 
Neonatal AEC cytokine/chemokine release across groups stratified by recent wheeze and 
reported eczema  
There were 53 children with neither wheeze nor eczema, 26 with eczema no wheeze, 5 with 
wheeze no eczema and 6 with both wheeze and eczema.  There was a difference (p=0.003) 
across the groups for IL-8/CXCL8 release after exposure to IL-1β and TNFα; median [IQR] 
values were as follows: no wheeze no eczema 108982 pg/mg protein [77893, 186455] n=52; 
eczema no wheeze 116590 [92410, 161968] n=26; wheeze no eczema 72085 [42748, 86760] 
n=4; wheeze and eczema 54955 [30680, 72003], n=6, figure 2.   
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DISCUSSION 
The present study was designed to relate in vitro nasal AEC release of pro-inflammatory 
mediators within 48 hours of birth to the presence of recent wheeze in these subjects at 
four years of age.  The main finding was that AEC from neonates who had recent wheeze at 
the age of four years had reduced release of IL-8/CXCL8 by neonatal AEC stimulated with IL-
1β and TNF-α compared to children without recent wheeze.  We also observed that when 
we stratified by eczema (a surrogate for atopy) there was no evidence that eczema modified 
the relationship between AEC function and recent wheeze.   Our results suggest that there is 
a congenital abnormality in AEC function which predisposes to childhood wheeze.  However, 
there were many children in our cohort who did not progress to wheeze but had similarly 
low AEC cytokine/chemokine responses to those who did wheeze, and this suggests that 
higher AEC responses may confer protection against wheeze in early childhood and also that 
post-natal factors, including second hand smoke, inhaled chemicals, mould, ambient air 
pollutants and respiratory viruses
3
, may be requir d for lower AEC responses to translate 
into asthma symptoms.  These results provide proof of concept but are based on a small 
number of individuals and require confirmation elsewhere. 
There is a substantial literature, summarised in two recent reviews
10,11
, which demonstrates 
that in vitro AEC function is different in children with asthma compared to those without 
asthma but what has been uncertain is whether the AEC dysfunction is the cause or the 
consequence of asthma. Nasal AEC from newborn infants who subsequently developed 
wheeze released less IL-8/CXCL8, IL-6 and GMCSF compared to non-wheezing controls
20
 and 
bronchial AEC from adults with asthma have evidence of reduced innate immune responses 
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after exposure to rhinovirus
12,13
.  The findings of our study are consistent with these studies 
from children and adults and suggest that the differences precede the onset of symptoms.   
There are some studies whose results are apparently inconsistent with our findings.  For 
example, three studies have reported no difference in IL-8/CXCL8 release from bronchial 
AEC in children with and without asthma
21–23
, while others have reported increased release 
of pro-inflammatory mediators, such as  IL-6
21
 and VEGF
24
, in children with asthma 
compared to asymptomatic peers.  One explanation for these apparent discrepancies 
between our study and others is that our AEC were assayed at a very early stage in the life-
course compared to others, and secondary upregulation of AEC release of mediators, such 
as IL-6 and VEGF, may occur after the neonatal period as the nasal epithelium becomes 
colonised by microbial flora, infected with respiratory viruses and exposed to airborne 
pollutants.  
There are a number of mechanisms which might explain why neonatal AEC 
cytokine/chemokine release was reduced in some individuals with recent wheeze at four 
years but this study was not designed to explore these mechanisms.  The reductions in 
neonatal cytokine/chemokine release seen among some individuals with recent wheeze 
might plausibly be due to a reduced ability to recognise and/or respond to stimulation.  
There was a reduction in IL-8/CXCL8 release in untreated culture among those with recent 
wheeze compared to those without, and this suggests that there may be a constitutive 
defect in cytokine/chemokine responses in addition to an attenuated cytokine/chemokine 
response to stimulation. We have demonstrated that inclusion of children with wheeze ever 
but not in the last year among the no wheeze group did not affect the results and therefore 
Page 11 of 32
John Wiley & Sons, Inc.
Pediatric Pulmonology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
11 
 
the inconsistent relationship between low cytokine/chemokine response and wheeze at 
four years is not explained by some children in this group having transient wheeze.    
There are some considerations which should be given to these results.  First, the sample size 
was relatively small with only eleven children having had recent wheeze.  However, the 
highly significant and large difference in IL-8/CXCL8 release (our cytokine/chemokine of 
primary interest) after exposure to IL-1β and TNF-α between children with and without 
wheeze is unlikely to be a false positive finding, as is the consistent reduction in AEC release 
of several cytokines/chemokines in association with later wheeze.  The response of the 
respiratory system to early infection is widely considered to be important to the later 
development of asthma
25
 and the inflammatory mediators  associated with later wheeze in 
this study are all recognised as being important to host airway response to infection: IL-
8/CXCL8 is a potent neutrophil chemo-attractant; IL-6 has both anti- and pro-inflammatory 
properties;
26
 and ICAM-1 is a ligand for LFA1 (a receptor found on leukocytes
27
) and a 
receptor rhinovirus
28
.  The analysis of AEC response after LPS exposure and where 
individuals were stratified by wheeze and eczema yielded very small groups with wheeze 
and these results should be treated with some caution.  Alternatively the group with eczema 
but not wheeze was adequate in size to infer that there was no substantial difference 
compared to the group with neither eczema nor wheeze.  Our study is limited by not 
collecting measurements of atopy or lung function.   An additional limitation of our study 
was that the cohort recruited included 25% of mothers with a history of asthma and 5% who 
smoked, whereas the corresponding proportions in the general population are 10% and 
20%, so these results may not be generalisable.  A final limitation is that we used a 
submerged model and an air-liquid interface model could have been more appropriate since 
it contains differentiated cells
10
.  
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In summary, these findings suggest that a congenital abnormality in AEC responses to 
stimuli predispose children to developing wheeze later in life.  The progress from wheeze in 
four year olds into diagnosed asthma in older children is not inevitable and we will follow up 
this group of children to determine whether the associations between neonatal AEC 
responses and wheeze persist.  In the meantime, these novel findings now require 
confirmation in larger and older populations.  
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FIGURE LEGENDS 
Figure one.  Scatter plot comparing interleukin (IL) -8/CXCL8 release from neonatal nasal 
airway epithelial cells after 24 hours exposure to either medium alone or medium plus IL-1β 
and tumour necrosis factor (TNF)-α for individuals with parent-reported wheeze in the last 
12 months at four years of age compared to no-wheeze controls. P values from Mann 
Whitney U test.  The horizontal lines indicate the mean IL-8/CXCL8 value. 
Figure two.  Scatter  plot comparing interleukin (IL)-8/CXCL8 release from neonatal nasal 
airway epithelial cells after 24 hours exposure to either medium alone or to medium plus IL-
1β and tumour necrosis factor (TNF)-α for individuals stratified by parent-reported wheeze 
in the last 12 months and history of eczema at four years of age compared with no-
wheeze/no eczema controls.    The p value is from the Kruskal-Wallis test.  There was no 
significant difference across the groups exposed to medium alone. The horizontal lines 
indicate the mean IL-8/CXCL8 value. 
 
 
Page 18 of 32
John Wiley & Sons, Inc.
Pediatric Pulmonology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
Figure one.  Scatter plot comparing interleukin (IL) -8/CXCL8 release from neonatal nasal airway epithelial 
cells after 24 hours exposure to either medium alone or medium plus IL-1β and tumour necrosis factor 
(TNF)-α for individuals with parent-reported wheeze in the last 12 months at four years of age compared to 
no-wheeze controls. P values from Mann Whitney U test.  The horizontal lines indicate the mean IL-8/CXCL8 
value.  
 
254x190mm (96 x 96 DPI)  
 
 
Page 19 of 32
John Wiley & Sons, Inc.
Pediatric Pulmonology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
Figure two.  Scatter  plot comparing interleukin (IL)-8/CXCL8 release from neonatal nasal airway epithelial 
cells after 24 hours exposure to either medium alone or to medium plus IL-1β and tumour necrosis factor 
(TNF)-α for individuals stratified by parent-reported wheeze in the last 12 months and history of eczema at 
four years of age compared with no-wheeze/no eczema controls.    The p value is from the Kruskal-Wallis 
test.  There was no significant difference across the groups exposed to medium alone. The horizontal lines 
indicate the mean IL-8/CXCL8 value.  
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Table one.  Comparison of maternal, paternal and neonatal characteristics for individuals in 
the original population recruited and those where questionnaire data were available at four 
years of age.  SIMD=Scottish Index of Multiple Deprivations. IQR= interquartile range. 
 Recruited 
(n=269 unless 
stated) 
Questionnaire 
data available 
(n=91 unless 
stated) 
 
 
 
Maternal 
details 
Mean maternal age (SD), years 31.0 (3.8) 30.9 (3.3) 
Number of primagravida mothers (%) 158 (59%) 52 (59%) 
Number of mothers smoking (%) 14 (5%) 2 (2%) 
Median SIMD (IQR)  5283           
(4592, 5993) 
5291           
(4769, 5993) 
Number of mothers with a history of asthma (%) 67 (25%) 20 (22%) 
Number of mothers with a history of eczema (%) 48 (18%) 10 (11%)* 
Number of mothers with a history of hayfever (%) 100 (37%) 30 (33%) 
 
Paternal 
details 
Number of fathers with a history of asthma (%) 56 (21%) 16 (18%) 
Number of fathers with a history of eczema (%) 30 (11%) 9 (10%) 
Number of fathers with a history of hayfever (%) 77 (29%) 28 (31%) 
 
 
 
 
Neonatal 
Male Sex (%) 134 (50%) 46 (51%) 
Mean birth weight (SD), kg 3.52 (0.55) 3.63 (0.40)* 
Median age when nasal brushing taken (IQR), hrs  26 (16, 45)  
n=192 
25 (16, 40) 
Median IL-8 concentration after exposure to IL-1β/TNFα†(IQR) 107635 (69320, 105685 (69933, 
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details 156720) 
n=134 
157073) 
n=88 
Median IL-6 concentration after exposure to IL-1β/TNFα† (IQR) 27670 (9874, 
56924) n=134 
28726 (9813, 
54007) 
n=88 
Median GMCSF concentration after exposure to IL-1β/TNFα† 
(IQR) 
693 (267, 1528) 
n=134 
705 (290, 1549) 
n=88 
*p<0.05 compared to all recruits.  †Units are pg/mg protein.  The increase in 
cytokine/chemokine concentration is relative to cytokine/chemokine release after exposure 
to growth medium alone.   
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Table 2.  Median (interquartile range) cytokine concentration in the supernatant from 
neonatal nasal airway epithelial cell culture in groups stratified by the presence of recent 
wheeze at four years of age.  The units are pg/mg protein. *p<0.001, †p=0.013, ‡p=0.012, 
¤p=0.017, ¶p=0.004, ¥p=0.038 and §p=0.049.      
 Mediator Recent wheeze at four 
years 
 
No recent wheeze 
 
Median concentration 
after treatment with IL-
1β and TNFα (IQR) 
IL-8/CXCL8 66080 (35470, 73988) 
n=10* 
112340 (83493,177776) 
n=78 
IL-6 7989 (2262, 27837) n=10† 30649 (12643, 54739) n=78 
GMCSF 130(64, 852) n=10‡ 867 (367, 1562) n=78 
ICAM-1 686 (270, 1253) n=10¤ 1288 (680, 2145) n=78 
Median concentration 
after treatment with 
lipopolysaccharide (IQR) 
IL-8/CXCL8 3750 (1720, 12480) n=5¶ 17810 (10260, 38130) n=33 
IL-6 2679 (897, 29650) n=5 9983 (741, 40795) n=33 
GMCSF 31 (12, 55) n=5 110 (13, 634) n=33 
ICAM-1 30 (12, 55) n=5 186 (33, 597) n=33 
Median concentration 
after treatment with 
house dust mite (IQR) 
IL-8/CXCL8 5215 (2615, 22575) n=10 19325 (6568, 35818) n=62 
IL-6 622 (55, 17112) n=10 15179 (1931, 25732) n=62 
GMCSF 5 (0, 460) n=10 131 (19, 346) n=62 
ICAM-1 48 (0, 255) n=10¥ 300 (87, 705) n=62 
 
Median concentration in 
untreated culture (IQR) 
IL-8/CXCL8 3530 (1850, 6310) n=11§ 6829 (3850, 13947) n=80 
IL-6 1470 (132, 8244) n=11 3884 (901, 10418) n=80 
GMCSF 12 (2, 212) n=11 40 (11, 227) n=80 
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ICAM 57 (0, 485) n=11 107 (0.00, 334) n=80 
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E-Table 1.  Comparison of maternal, paternal and neonatal characteristics for individuals in the 
original population recruited and those where neonatal airway epithelial cells cytokine/chemokine 
responses were available.  LPS=lipopolysaccharide.  IL=interleukin. TNF=Tumour Necrosis Factor, 
HDM=House Dust Mite. SIMD=Scottish Index of Multiple Deprivations. IQR= interquartile 
range.*p<0.05 compared to all recruited. 
 Recruited 
(n=269 
unless 
stated) 
Untreated 
culture (n=91 
unless stated) 
Culture 
treated with 
IL-1β/TNFα 
(n=88 unless 
stated) 
Culture 
treated with 
HDM (n=72 
unless 
stated) 
Culture 
treated with 
LPS (n=38 
unless stated) 
Mean maternal age (SD), years 31.0 (3.8) 30.9 (3.3) 30.8 (3.3)  30.7 (3.2) 31.2 (3.3) 
Number of primagravida mothers (%) 158 (59%) 52 (59%) 52 (59%) 43 (60%) 24 (63%) 
Number of mothers smoking every day (%) 14 (5%) 2 (2%) 2 (2%) 2 (3%) 0 
Median SIMD (IQR)  5283           
(4592, 5993) 
5291           
(4769, 5993) 
5291    
(4769, 5965) 
5290    
(4775, 5930) 
5470       
(5134, 6048) 
Number of mothers with a history of 
asthma (%) 
67 (25%) 20 (22%) 20 (23%) 14 (19%) 7 (18%) 
Number of mothers with a history of 
eczema (%) 
48 (18%) 10 (11%)* 10 (11%) 9 (13%) 5 (13%) 
Number of mothers with a history of 
hayfever (%) 
100 (37%) 30 (33%) 29 (33%) 21 (29%) 14 (37%) 
Number of fathers with a history of asthma 
(%) 
56 (21%) 16 (18%) 16 (18%) 15 (21%) 8 (21%) 
Number of fathers with a history of eczema 
(%) 
30 (11%) 9 (10%) 9 (10%) 7 (10%) 5 (13%) 
Number of fathers with a history of 77 (29%) 28 (31%) 28 (32%) 21 (29%) 12 (32%) 
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hayfever (%) 
Male Sex (%) 134 (50%) 46 (51%) 44 (50%) 37 (51%) 17 (45%) 
Mean birth weight (SD), kg 3.52 (0.55) 3.63 (0.43)* 3.62 (0.43)* 3.62 (0.43)* 3.62 (0.41) 
Median age when nasal brushing taken 
(IQR), hrs   
26 (16, 45)  
n=192 
25 (16, 40) 25 (16, 40) 28 (19, 40) 29 (17, 42) 
Median increase  in IL-8 concentration after 
exposure to IL-1β/TNFα†(IQR) 
95945 
(61210, 
143640) 
n=134 
- 95680 
(61925, 
142645) 
93100 
(60190, 
140500) 
94310   
(62675, 
162712) 
Median increase in IL-6 concentration after 
exposure to IL-1β/TNFα† (IQR) 
21914 
(6998, 
50034) 
n=134 
- 21914 
(6357, 
48714) 
22307  
(6368, 
50227) 
26960     
(5571, 53452) 
Median increase in GMCSF concentration 
after exposure to IL-1β/TNFα† (IQR) 
633 (218, 
478) 
n=134 
- 629 (276, 
1446) 
632 (279, 
1450) 
701 (254, 
1478) 
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E-Table 2.  Median (interquartile range) cytokine concentration in the supernatant from neonatal 
nasal airway epithelial cell culture after treatment with house dust mite in groups stratified by the 
presence of recent wheeze at four years of age.  The units are pg/mg protein. The difference in 
RANTES was significant (p=0.042) but none of the other comparisons between groups were 
significant. ND=not detected. 
Mediator Wheeze at four years 
n=10 
No wheeze 
n=62 
VEGF 1696[667.2, 3113] 2427 [1324, 3731] 
RANTES/CCL5 3.0 [1.1, 41.8]* 14.3 [3.4, 115.2] 
MCP-1/CCL2 568 [ND, 91.9] 40.1 [6.8, 169.6] 
IL-3 1.6 [ND, 7.6] 3.7 [1.1, 7.2] 
IL-10 0.2 [ND, 1.1] ND [ND, 8.2] 
IL-17A 0.3 [ND, 1.7] ND [ND, 0.1] 
IFN-ɣ ND [ND, 0.6] ND [ND, 8.2] 
eotaxin ND [ND, ND] ND [ND, ND] 
MIP1-α/CCL3 5.2[ND,  22.1] ND [ND, 2.3] 
MIP1-β/CCL4 0.1 [ND, 2.6] 0.8 [ND, 9.2] 
TNF 56.4 [1.9, 100.0] 35.4 [3.9, 166.6] 
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E-Table 3.  Median (interquartile range) cytokine concentration in the supernatant from neonatal 
nasal airway epithelial cell culture after treatment with IL-1β and TNFα  in groups  stratified by the 
presence of recent wheeze at four years of age.  The units are pg/mg protein. There were no 
significant differences in cytokine concentration between the two groups. ND=not detected 
Mediator Wheeze at four years 
n=10 
 
No wheeze 
n=78 
 
VEGF 2631 [1912, 4983]  4646 [254, 6392] 
RANTES/CCL5 142 [15, 287] 131 [26, 377]  
MCP-1/CCL2 283 (50, 1890) 1021 [272, 2624]  
IL-3 ND [ND, 1.1] ND [ND, 1.4] 
IL-10 ND [ND, 1.8] ND [ND, 1.6] 
IL-17A ND [ND, 2.6] ND [ND, 3.5] 
IFN-ɣ ND [ND, 3.6] ND [ND, 2.8] 
eotaxin ND [ND, 4.2] ND [ND, 2.3] 
MIP1-α/CCL3 ND [ND, 14.3] ND [ND, 21.2] 
MIP1-β/CCL4 48.6 [10.8, 213.8] 56 [18, 173] 
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E-Table 4.  Median (interquartile range) cytokine concentration in the supernatant from neonatal 
nasal airway epithelial cell culture after treatment with lipopolysaccharide in groups stratified by the 
presence of recent wheeze at four years of age.  The units are pg/mg protein. There were no 
significant differences in cytokine concentration between the two groups. ND=not detected. 
Mediator Wheeze at four years 
n=5 
No wheeze 
n=33 
VEGF 2836 [1712, 3564] 2862 [1817, 1396] 
RANTES/CCL5 3.1 [1.5, 5.9] 3.4 [1.2, 7.4] 
MCP-1/CCL2 14.5 [3.8, 155.1] 36.1 [9.6, 188] 
IL-3 2.9 [1.0, 4.7] 2.0 [ND, 11.2] 
IL-10 1.1 [0.4, 2.8] 1.5 [ND, 5.1] 
IL-17A 1.7 [ND, 10.7] ND [ND, 5.7] 
IFN-ɣ ND [ND, 6.0] 1.9 [ND, 5.2] 
eotaxin ND [ND, 0.2] ND [ND, 3.6]  
MIP1-α/CCL3 ND [ND, 9.2] ND [ND, 10.5] 
MIP1-β/CCL4 ND [ND, 3.6] ND [ND, 0.6] 
TNF 4.5 [0.9, 8.8] 11.4 [5.1, 18.8]  
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E-Table 5.  Median (interquartile range) absolute cytokine concentration in the supernatant from 
neonatal nasal airway epithelial cell culture where cells were only exposed to medium alone in 
groups stratified by the presence of recent wheeze at four years of age.  The units are pg/mg 
protein. There were no significant differences in cytokine concentration between the two groups.  
ND=not detected 
Mediator Wheeze at four years 
 
No wheeze 
n=78 
VEGF 1295 [857, 2972] 2335 [1186, 4052] 
RANTES/CCL5 2.7 [ND, 13.4] 3.4 [ND, 7.0] 
MCP-1/CCL2 0.5 [ND, 8.7] 5.0 [ND, 75.2] 
IL-3 ND [ND, 1.1] ND [ND, 1.8] 
IL-10 ND [ND, 0.9] ND [ND, 0.5] 
IL-17A ND [ND, ND] ND[ ND, 0.1] 
IFN-ɣ ND [ND, 0.5] ND [ ND, 0.9] 
eotaxin ND [ND, ND] ND [ND, ND] 
MIP1-α/CCL3 ND [ND, 4.0] ND [ND, 4.2] 
MIP1-β/CCL4 ND [ND, 0.1] ND [ND, ND] 
TNF 0.2 [ND, 8.7] ND [ND, 1.4] 
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E-Table 6.  Median (interquartile range) cytokine concentration in the supernatant from neonatal nasal airway epithelial cell culture in groups stratified by 
wheeze outcome by four years of age.  The units are pg/mg protein. *p<0.001, †p=0.035, ‡p=0.004, ¶p=0.031 and ¥p=0.025 for comparison with no wheeze 
reported.  NR=no results available    
 Mediator Recent wheeze  at four years Wheeze resolved by four years 
 
No wheeze reported 
 
Absolute increase in 
concentration after 
treatment with IL-1β and 
TNFα  
IL-8/CXCL8* 55785 (33470, 69303) (n=10)* 73950 (53010, 108010) n=5 116550 (86895, 183980)(n=73) 
IL-6 6361 (1559, 24745) (n=10) † 32655 (14105, 35102) (n=5) 29373 (12299, 56938) (n=73) 
GMCSF 76 (22, 613) (n=10)‡ 299 (87, 580) (n=5) 1050 (432, 1686) (n=73) 
ICAM 541 (222, 1200) (n=10) 986 (520, 2808) (n=5) 1322 (684, 2146) (n=73) 
 Absolute increase in 
concentration after 
treatment with 
lipopolysaccharide  
IL-8/CXCL8 2200 (0, 7970) (n=5)¶ NR 17810 (10260, 38130) (n=33) 
IL-6 2252 (0, 21447) (n=5) NR 9983 (741, 40795) (n=33) 
GMCSF 16 (0, 428) NR 110 (13, 637) (n=33) 
ICAM 15 (0, 425) NR 186 (33, 597) (n=33) 
Absolute increase in IL-8/CXCL8 2450 (1350, 60630) (n=10) 30900 (17295, 34665) (n=5) 18120(6150, 36880) (n=57) 
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concentration after 
treatment with house 
dust mite  
IL-6 343 (0, 7897) (n=10) 19898 (8921, 27034) (n=5) 15093 (1245, 25941) (n=57) 
GMCSF 0 (0, 66) (n=10) 196 (18, 546) (n=5) 126 (18, 353) (n=57) 
ICAM 22 (0, 117) (n=10)¥ 578 (197, 973) (n=5) 293 (60, 717) (n=57) 
 
Untreated culture 
IL-8/CXCL8 3530 (1850, 6310) (n=11) 7570 (2250, 12930) (n=5) 6740 (3940, 14410) (n=75) 
IL-6 1470 (132, 8244) (n=11) 8803 (1246, 20594) (n=5) 3782 (897, 10440) (n=75) 
GMCSF 12 (2, 212) (n=11) 16 (2, 279) (n=5) 43 (11, 242) (n=75) 
ICAM 57 (0, 485) (n=11) 198 (0, 561) (n=5) 100 (0, 334) (n=75) 
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